Cargando…
Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients
Neural stem cells (NSCs) are tumor tropic and can be genetically modified to produce anti-cancer therapies locally in the brain. In a prior first-in-human study we demonstrated that a single dose of intracerebrally administered allogeneic NSCs, which were retrovirally transduced to express cytosine...
Autores principales: | Portnow, Jana, Badie, Behnam, Blanchard, M. Suzette, Kilpatrick, Julie, Tirughana, Revathiswari, Metz, Marianne, Mi, Shu, Tran, Vivi, Ressler, Julie, D’Apuzzo, Massimo, Aboody, Karen S., Synold, Timothy W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843788/ https://www.ncbi.nlm.nih.gov/pubmed/32895489 http://dx.doi.org/10.1038/s41417-020-00219-y |
Ejemplares similares
-
Early Changes in Tumor Perfusion from T1-Weighted Dynamic Contrast-Enhanced MRI following Neural Stem Cell-Mediated Therapy of Recurrent High-Grade Glioma Correlate with Overall Survival
por: Sahoo, Prativa, et al.
Publicado: (2018) -
Quantitative Evaluation of Intraventricular Delivery of Therapeutic Neural Stem Cells to Orthotopic Glioma
por: Gutova, Margarita, et al.
Publicado: (2019) -
Systemic Anti–PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal Fluid
por: Portnow, Jana, et al.
Publicado: (2020) -
GMP Production and Scale-Up of Adherent Neural Stem Cells with a Quantum Cell Expansion System
por: Tirughana, Revathiswari, et al.
Publicado: (2018) -
Pituitary metastasis: a rare condition
por: Javanbakht, Aida, et al.
Publicado: (2018)